Sign Out
Apo-Mometasone Aqueous Nasal Spray is indicated for use in adults and children 3 years of age and older to treat the symptoms of seasonal or perennial allergic rhinitis.
In patients who have a history of moderate to severe symptoms of seasonal allergic rhinitis, prophylactic treatment with Apo-Mometasone Nasal Spray is recommended two to four weeks prior to the anticipated start of the pollen season.
Apo-Mometasone Nasal Spray is indicated for the treatment of nasal polyps in patients 18 years of age and older. Treatment of nasal polyps in pediatric patients less than 18 years of age has not been established.
Apo-Mometasone Nasal Spray is indicated for the treatment of mild to moderate uncomplicated acute rhinosinusitis in patients 12 years of age and older without signs and symptoms of severe bacterial infection.
